Drug Shortage Report for QUELICIN

Last updated on 2025-03-12 History
Report ID 198410
Drug Identification Number 00038172
Brand name QUELICIN
Common or Proper name QUELICIN
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) SUCCINYLCHOLINE CHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 25 x 10mL vial
ATC code M03AB
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-07-12
Estimated end date
Actual end date 2025-03-11
Shortage status Resolved
Updated date 2025-03-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2025-03-12 English Compare
v14 2025-03-11 French Compare
v13 2025-03-11 English Compare
v12 2024-09-04 French Compare
v11 2024-09-04 English Compare
v10 2024-08-07 French Compare
v9 2024-08-07 English Compare
v8 2024-07-19 French Compare
v7 2024-07-19 English Compare
v6 2024-01-30 English Compare
v5 2023-11-17 English Compare
v4 2023-08-01 French Compare
v3 2023-08-01 English Compare
v2 2023-07-12 French Compare
v1 2023-07-12 English Compare

Showing 1 to 15 of 15